Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Abstract

Background Previous studies have shown that alendronate can increase bone mineral density (BMD) and prevent radiographically defined (morphometric) vertebral fractures. The Fracture Intervention Trial aimed to investigate the effect of alendronate on the risk of morphometric as well as clinically evident fractures in postmenopausal women with low bone mass. Methods Women aged 55-81 with low femoral-neck BMD were enrolled in two study groups based on presence or absence of an existing vertebral fracture. Results for women with at least one vertebral fracture at baseline are reported here. 2027 women were randomly assigned placebo (1005) or alendronate (1022) and followed up for 36 months. The dose of alendronate (initially 5 mg daily) was increased (to 10 mg daily) at 24 months, with maintenance of the double blind. Lateral spine radiography was done at baseline and at 24 and 36 months. New vertebral fractures, the primary endpoint, were defined by morphometry as a decrease of 20% (and at least 4 mm) in at least one vertebral height between the baseline and latest follow-up radiograph. Non-spine clinical fractures were confirmed by radiographic reports. New symptomatic vertebral fractures were based on self-report and confirmed by radiography. Findings Follow-up radiographs were obtained for 1946 women (98% of surviving participants). 78 (8.0%) of women in the alendronate group had one or more new morphometric vertebral fractures compared with 145 (15.0%) in the placebo group…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(96)07088-2

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 3,846

Metadata

Authors
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., Ott, S. M., Torner, J. C., Quandt, S. A., Reiss, T. F., & Ensrud, K. E.
Affiliations
  • University of California, San Francisco (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • University of Pittsburgh (US)
  • Stanford University (US)
  • VA Palo Alto Health Care System (US)
  • University of Washington (US)
  • University of Iowa (US)
  • Wake Forest University (US)
  • University of Minnesota (US)
Corresponding author
Black, Dennis M
Venue
The Lancet
Publisher
Elsevier BV
Published
1996-12
Volume
348
Issue
9041
Pages
1535-1541
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2153009489
Cited by
3,846
References
34
Citations by year
2026: 37 · 2025: 67 · 2024: 52 · 2023: 61 · 2022: 67 · 2021: 82 · 2020: 95 · 2019: 75 · 2018: 88 · 2017: 88 · 2016: 100 · 2015: 123 · 2014: 135 · 2013: 160 · 2012: 154
FWCI
124.37
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Neurological Disorders and Stroke (R01NS048597)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
alendronate, bisphosphonates, vertebral fractures, postmenopausal women, osteoporosis, fracture risk, hip fracture, wrist fractures, femoral neck bone mineral density, osteopenia, Fracture Intervention Trial, bone mineral density, fracture prevention, treatment discontinuation, adverse effects, drug safety, cost-effectiveness, quality of life
MeSH terms
Aged, Aged, 80 and over, Female, Femur Neck, Follow-Up Studies, Hip Fractures, Humans, Middle Aged, Radiography, Risk, Bone Density, Osteoporosis, Postmenopausal, Spinal Fractures, Alendronate, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. https://app.cochat.ai/papers/10.1016/s0140-6736(96)07088-2
The paper
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., Ott, S. M., Torner, J. C., Quandt, S. A., Reiss, T. F., & Ensrud, K. E. (1996). Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. The Lancet. https://doi.org/10.1016/s0140-6736(96)07088-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.